World Bulletin / News Desk
EU antitrust regulators charged Danish drugmaker Lundbeck, German peer Merck KGaA and seven other firms with blocking the entry of cheaper generic medicines into the market, in a move that could lead to big fines for the companies.
The charges against Lundbeck and the eight other firms are the first by the EU watchdog against "pay-for-delay" deals -- where brand-name companies pay generic competitors to abstain from putting their rival drugs on the market -- since a high-profile inquiry into the sector in 2009.
The European Commission said on Wednesday the tactic breached EU antitrust rules. It also warned French drugmaker Servier and several generic rivals of further action in the coming days for a similar offence, related to another medicine.
Regulators had said then that such delays cost European consumers billions of euros. Reuters reported on Tuesday that the EU watchdog would act against Lundbeck and Servier.
Companies can be fined up to 10 percent of their turnover if found guilty of breaching EU rules. Lundbeck posted 16 billion Danish crowns ($2.60 billion) in revenues last year.
The Commission said Lundbeck's action together with four generic competitors related to the antidepressant citalopram.
"The companies entered into agreements that foresaw substantial value transfers from Lundbeck to its four generic competitors, who subsequently abstained from entering the market with generic citalopram," the Commission said in a statement.
"The value transfers included direct payments from Lundbeck to the generic competitors and also occurred in other forms, such as the purchase of generic citalopram stock for destruction or guaranteed profits in a distribution agreement," it said.
The Commission has been stepping up scrutiny of settlements between drug companies in recent years over concerns some may prevent consumers from obtaining lower-priced medicines.
Lundbeck said it did not believe it had broken EU rules.
"Lundbeck vigorously opposes any allegation of wrongdoing and does not believe its practice has violated European competition law," the company said in a statement in Copenhagen.
The EU watchdog also sent the "statement of objections" or charge sheet to Generics UK, Arrow, Resolution Chemicals, Xellia Pharmaceuticals, Alpharma, A.L. Industrier and Ranbaxy .
On Servier, the Commission said it planned to act against the company and several generic competitors soon.
"Servier and several generic competitors entered into agreements which may have hindered the entry of generic perindopril into markets in the EU," the regulators said.
"In the context of this investigation, the Commission is also looking at the unilateral behaviour of Servier."
Smuggling is denying Tanzania some 80 percent of receipts accrued from the precious gemstone
The Africa initiative will create "one huge free-trade union" allowing foreign investors in Egypt to more easily reach 260 million consumers from South Africa to Ethiopia.
Budapest says the collapse of the rival Western-backed Nabucco project to bring gas from Azerbaijan to Europe, and stalled plans to build inter-connector pipelines within eastern Europe, have left it with no alternative.
In Russia, the idea of a Saudi-U.S. plot against Moscow has become common currency as the economy struggles under the effects of low oil prices and Western sanctions imposed
Lithuania's new LNG terminal represents an end to Russia's gas monopoly in Lithuania, says Lithuania's president
The minister said the militants considered the eastern Syrian cities "safe for them" and thus transferred wheat and barley in Nineveh "to preserve it".
Decreasing oil prices are intended to pressurize and punish Iran and Russia: Int. Financial Markets expert says
Prices rise 30 percent as new president's deeply unpopular subsidy cut takes effect.
Japan's prime minister is to turn to the polls to see if his decision not to hike taxes can gain electoral support.
The agreement between the two countries, which trade around $3.2 billion in goods each year, will enable New Zealand to better compete with other countries in its sixth-largest export market.
G20 summit in Brisbane produced 800 commitments after two days of talks
The agreement gives Australian dairy farmers tariff-free access within four years to China's lucrative infant formula market, minus any of the "safeguard" caps that currently restrict competitors from New Zealand.
The shockingly downbeat report reinforced expectations Prime Minister Shinzo Abe will delay a sales tax hike, set for October next year, after a hike in the tax in April took a heavy toll on consumption.
More than 120 foreign and domestic companies are currently engaged in horticulture development efforts in Ethiopia.
Security and climate change overshadowed G20 talks on boosting global economic growth at the summit
Supporting small and medium-sized industry is also be a focus for the Turkish G20 presidency, Deputy PM said.